{"schema_version":"secwatch.filing_event.v1","accession":"0001933414-26-000090","form_type":"8-K","ticker":"MLYS","cik":"0001933414","company_name":"Mineralys Therapeutics, Inc.","filed_at":"2026-05-22T20:50:14+00:00","discovered_at":"2026-05-22T20:51:00.336398+00:00","generated_at":"2026-05-22T20:52:23.219999+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"confidence":"high","headline":"Mineralys Therapeutics 2026 annual meeting results: directors elected, auditor ratified","bullets":["Elected three Class III directors to serve until 2029: Akkaraju (67.1M for), Slingsby (67.1M for), Karydas (66.6M for).","Ratified Ernst & Young as independent auditor for fiscal year 2026 with 72.6M votes for, 9.5K against.","Broker non-votes of 5.6M shares on director election proposals; no non-votes on auditor ratification.","All proposals passed with requisite affirmative votes as described in the April 8, 2026 proxy statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001933414-26-000090","json":"https://secwatch.observer/filing/0001933414-26-000090.json","markdown":"https://secwatch.observer/filing/0001933414-26-000090.md","text":"https://secwatch.observer/filing/0001933414-26-000090.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1933414/000193341426000090/0001933414-26-000090-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1933414/000193341426000090/mlys-20260521.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T20:52:23.219999+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}